RxSight Inc (RXST)
51.26
+0.16
(+0.32%)
USD |
NASDAQ |
Nov 04, 16:00
51.26
0.00 (0.00%)
After-Hours: 20:00
RxSight Revenue (Quarterly): 34.89M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 34.89M |
| March 31, 2024 | 29.51M |
| December 31, 2023 | 28.58M |
| September 30, 2023 | 22.20M |
| June 30, 2023 | 20.81M |
| March 31, 2023 | 17.49M |
| December 31, 2022 | 16.09M |
| September 30, 2022 | 12.62M |
| June 30, 2022 | 11.36M |
| Date | Value |
|---|---|
| March 31, 2022 | 8.942M |
| December 31, 2021 | 8.426M |
| September 30, 2021 | 5.786M |
| June 30, 2021 | 4.897M |
| March 31, 2021 | 3.484M |
| December 31, 2020 | 4.914M |
| September 30, 2020 | 4.17M |
| June 30, 2020 | 2.706M |
| March 31, 2020 | 2.888M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.706M
Minimum
Jun 2020
34.89M
Maximum
Jun 2024
13.32M
Average
10.15M
Median
Revenue (Quarterly) Benchmarks
| Tandem Diabetes Care Inc | 221.91M |
| Twist Bioscience Corp | 81.46M |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 29.94M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.079M |
| Total Expenses (Quarterly) | 43.22M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | 1.795B |
| Gross Profit Margin (Quarterly) | 69.51% |
| Profit Margin (Quarterly) | -17.42% |
| Earnings Yield | -1.97% |
| Normalized Earnings Yield | -1.909 |